| Analyst | Bewertung | Kursziel | Kurs | Abstand | Datum |
|---|---|---|---|---|---|
| Jefferies | 210,07 € | 166,4736 € | 43,5964 € | 05.11.26 | |
| DZ | 190,66 € | 164,487 € | 26,1699 € | 03.11.26 | |
| Goldman | 210,94 € | 164,487 € | 46,4554 € | 03.11.26 | |
| UBS | 191,63 € | 166,3516 € | 25,2804 € | 02.11.26 | |
| Barclays | 203,61 € | 166,3516 € | 37,2574 € | 02.11.26 | |
| Deutsche Bank | 140,00 € | 166,3516 € | -26,3494 € | 02.11.26 | |
| RBC | 182,70 € | 166,3516 € | 16,3434 € | 02.11.26 | |
| Bernstein | 237,36 € | 167,0695 € | 70,2929 € | 30.10.26 | |
| JPMorgan | 191,07 € | 152,5381 € | 38,5339 € | 27.10.26 | |
| Berenberg | 177,78 € | 146,9919 € | 30,7881 € | 16.10.26 |
| Name | Positiv | Neutral | Negativ | Ø Kursziel | Kurs | Abstand |
|---|---|---|---|---|---|---|
| AstraZeneca plc | 9 | 1 | 0 | 193,58 € | 167,35 € | 26,23 € |
| Glaxo Smith Kline plc | 2 | 5 | 2 | 24,45 € | 22,65 € | 1,80 € |